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ABSTRACT
Objectives: The incidence and prevalence of allergies
worldwide has been increasing and allergy services
globally are unable to keep up with this increase in
demand. This systematic review aims to understand the
delivery of allergy services worldwide, challenges faced
and future directions for service delivery.
Methods: A systematic scoping review of Ovid,
EMBASE, HMIC, CINAHL, Cochrane, DARE, NHS EED
and INAHTA databases was carried out using
predefined inclusion and exclusion criteria. Data on the
geographical region, study design and treatment
pathways described were collected, and the findings
were narratively reported. This review followed the
Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) guidelines.
Results: 205 publications were screened and 27
selected for review. Only 3 were prospective studies,
and none included a control group. There were no
eligible publications identified from North America,
Africa, Australia and most parts of Asia. Most
publications relate to allergy services in the UK. In
general, allergy services globally appear not to have
kept pace with increasing demand. The review
suggests that primary care practitioners are not being
adequately trained in allergy and that there is a paucity
of appropriately trained specialists, especially in
paediatric allergy. There appear to be considerable
barriers to service improvement, including lack of
political will and reluctance to allocate funds from local
budgets.
Conclusions: Demand for allergy services appears to
have significantly outpaced supply. Primary and
secondary care pathways in allergy seem inadequate
leading to poor referral practices, delays in patient
management and consequently poor outcomes.
Improvement of services requires strong public and
political engagement. There is a need for well-planned,
prospective studies in this area and a few are currently
underway. There is no evidence to suggest that any
given pathway of service provision is better than
another although data from a few long-term,
prospective studies look very promising.
INTRODUCTION
The incidence and prevalence of allergic dis-
eases has been steadily increasing globally.1 It
is recognised that there has been an increase
in the prevalence of allergies in children and
young adults with each passing decade.2
Despite this increasing need, allergy services
have not improved worldwide.3 It is now well
established that developed countries bear a
higher burden of allergic disease.1 4–6
However, services rendered to the affected
individuals in these higher income countries
remain inadequate with deﬁciencies in
primary and secondary care provision.3 7 The
picture is similar across many countries with
long waiting times for specialist appoint-
ments and wide heterogeneity in provision of
primary care and specialist services.7 8 In
addition, the growing incidence of serious
allergic manifestations such as anaphylaxis9–
12 as well as that of individuals with multiple,
complex allergies13 has prompted calls for
improved services worldwide.3 13
The UK has one of the highest rates of
allergy and related diseases in the western
hemisphere1 with a steady increase in the
prevalence, severity and complexity of aller-
gic disease in the last two to three
decades.2 14–17 It is estimated that 30% of all
adults and 40% of children in the UK will be
affected by allergy-related conditions.18
Nevertheless, allergy services have remained
‘woefully poor’18 with very limited and
patchy specialist service availability. This
shortfall in service availability and the inher-
ent heterogeneity of limited available services
has been the focus of multiple expert body
reviews in the UK, which have called for
Strengths and limitations of this study
▪ The literature review was carried out using eight
major databases and reporting followed the
PRISMA guidelines.
▪ This is comprehensive review of all the published
reports and journal articles on allergy services.
▪ No eligible publications were identified from
large geographical areas such as North America,
Africa, Australia and most of Asia; most publica-
tions were UK based.
▪ Service pathways for allergy and eczema were
considered in the review.
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increased investment in allergy management and for
reorganisation of allergy services.18–22
One of the major barriers to service planning in
allergy is the lack of political engagement and reluc-
tance to allocate funds from the local budget for improv-
ing allergy services.23 24 Allergy is not generally
perceived as a serious condition with major implications
for health and quality of life. There is a growing body of
evidence to the contrary, however. It is now established
that children with food allergies are more anxious than
those with insulin-dependent diabetes and tend to have
overprotective and very anxious parents.25 This is also
true of adolescents with a history of anaphylaxis.26 In
addition, the costs of allergies can be considerable.
Allergy and related conditions are estimated to cost
the UK NHS about £1 billion per year.27 Productivity
losses associated with allergic rhinitis in the USA were
higher than those due to stress, migraine and de-
pression.28 Studies have shown that effective allergy
services can not only improve quality of life, but can
also be cost-saving.29 30 Hence, there is an urgent
need to impress on policymakers the importance and
wisdom of investing in the improvement of allergy
services.
There is currently no agreement on how allergy ser-
vices should be structured. In the UK and Europe,
Primary Care Physicians – known as GPs or General
Practitioners in the UK – (PCPs) diagnose and manage
the majority of individuals with allergies7 whereas in
Australia and the USA, specialist services provide the bulk
of allergy care.8 Allergy service delivery by non-clinician
practitioners such as pharmacists and dieticians, while
possible, is not optimally used.22 Various pathways have
been suggested and are being tested.23 31 32 However, it is
not yet clear whether any particular model of service
delivery may be preferable to the others.
The aim of this systematic review is to assess published
approaches to allergy service delivery. The objective is to
identify and appraise these publications to gain an
understanding of the advantages as well as challenges
associated with these service pathways; and also to
explore current ideas regarding the future direction for
these services.
METHODS
The Preferred Reporting Items for Systematic Reviews
and Meta-analyses (PRISMA) guidelines were followed in
conducting this systematic scoping review. The PRISMA
checklist is supplied as online supplementary ﬁle S1.
Data sources and search strategy
A systematic search of the literature was carried out to
identify articles related to allergy service pathways in
humans. Search terms included allergy, eczema, care,
service and pathway (see online supplementary ﬁle S2).
MEDLINE, EMBASE, HMIC, CINAHL, Cochrane,
DARE, NHS EED and INAHTA websites were searched
for the purposes of this review. Searches included publi-
cations indexed until the 4th of October 2016. In order
for the MEDLINE searches to be relevant, we stipulated
that two papers selected a priori3 33 should be identiﬁed
in the search. References within the publications identi-
ﬁed as relevant were individually examined to identify
more articles of interest. Publications citing the chosen
articles were also carefully examined for relevance.
Selection of literature
After discarding duplicates, the title and abstract of the
articles were examined for relevance. Where these were
not informative, the full text of the publication was
reviewed. Articles were included for review if they dis-
cussed pathways for the delivery of allergy or eczema ser-
vices. Publications which reported opinions, conference
abstracts, case reports or case series were excluded.
Non-English language articles were not included in the
review. Asthma service pathways were also not consid-
ered. One of the researchers (LD) carried out the
searches with help and advice from an information spe-
cialist from the University of Birmingham. LD screened
all the articles as per the predetermined criteria. A total
of 50% of the unselected articles (25% each) were
reviewed independently by two of the coauthors (TR
and CC). Disagreements, if any, were resolved through
discussion and consensus.
The PRISMA ﬂow chart for selection of articles is
shown in ﬁgure 1.
Data extraction and analysis
The data extraction form was piloted initially using a few
publications. Appropriate modiﬁcations were made
before starting the full extraction process.
The data were extracted by LD using extraction table
that was previously agreed with the coauthors. Data
extraction was scrutinised independently by two other
authors (CC and TR).
For each publication, the author, year of publication,
geographical region of interest, type of study (report,
discussion, consensus, etc), study design (prospective,
retrospective, cross section), treatment pathway
(primary, secondary or both), principal ﬁndings and key
recommendations were extracted.
Most of the articles were descriptive; hence the ana-
lysis followed a narrative synthesis. This is common in
reviews of very heterogeneous studies which aim to
describe and scope the area of interest.34 Since the
objective of the report was to explore options for
service delivery, the review was designed to be inclusive.
Publications were, therefore, not excluded based on
quality criteria but were described and brieﬂy critiqued
as appropriate given the nature of the studies. We
aimed to map the current literature and understand
the type of evidence available in this area (ie, allergy
pathways).
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RESULTS
The database search identiﬁed 351 articles of which
158 were duplicates. Additional 12 articles were
included following reference and citation searches.
After consideration of the title and abstract, a further
142 articles were excluded and a total of 63 publica-
tions were screened thoroughly for their relevance to
the review. Figure 1 shows a ﬂow diagram of the papers
screened, identiﬁed, retained or excluded at each
stage, and the reasons for exclusion of articles as per
the PRISMA guidelines.35
Twenty-seven publications were included in the ﬁnal
review which are summarised in table 1. Only three pub-
lications describe prospective data collection alongside
service reorganisation.23 43 52 There were no eligible pro-
spective, randomised controlled trials identiﬁed.
Figure 1 Flow diagram showing the stages involved in choosing eligible publications for the systematic review (based on the
PRISMA recommendations).
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Table 1 Summary of characteristics of the included publications (arranged in chronological order)
Author, (year) (ref)
Level
Region Type of study Study aim 1° 2° Salient findings Key recommendations Comments
Isinkaye et al
(2016)36
UK Retrospective cohort
study
To ascertain what
proportion of referrals to
secondary care could be
managed a by GP with
special interest in allergy
✓ ▸ At least two-fifths of all
referrals to specialists
(42%) were felt to be
appropriate for a GPwSI
setting.
▸ There was some
disagreement between
reviewers re: suitability of a
further 30% of the referrals
▸ Intraobserver variation was
also seen (ie, reviewer
changed their initial opinion
on referral after seeing the
letter from specialist).
▸ GPwSI in allergy could
effectively identify and
manage a large proportion
of referrals made to
paediatric allergy
specialists.
▸ This service should be
introduced alongside other
initiatives to improve UK
allergy services.
▸ The GP referral letters and the
clinic letters from specialists
were reviewed by three
paediatric allergists.
▸ Generalisability of results may
be an issue, although GPwSI
shown to be useful by Levy
et al as well.
▸ The authors used an agreed
set of criteria for the
competencies expected of a
GPwSI (not provided with the
paper).
Krishna et al
(2016)37
UK Report/non-systematic
literature review
To discuss the potential
use of telemedicine in
pathways for diagnosis
and management of adult
allergies
✓ ✓ ▸ Adult allergy services can
potentially benefit from
telemedicine. Various
pathways are suggested.
▸ Algorithms for possible
management of allergic
rhinitis, urticaria and
anaphylaxis via
telemedicine are discussed
Authors advise that
prospective studies evaluating
these techniques should be
planned
▸ Telemedicine used
successfully in some areas of
medicine, but systematic
prospective studies in allergy
are lacking.
▸ There are potential issues with
clinical governance and
confidentiality Lack of
adequately trained specialists
can affect implementation of
these measures.
Bousquet et al
(2015)38
Europe Introduction of
prospective study
using Information and
communications
technology (ICT)
methods.
Plan for study with ICT
methods in allergy
services.
✓ ✓ ▸ Many gaps in allergy
diagnosis and management
exist which could be
addressed using advances
in ICT.
▸ The use of Visual Analog
scoring, e-allergy and
MASK aerobiology apps
can help in diagnosis,
management and
monitoring of allergic
rhinitis.
▸ The systems will be based
on ARIA and International
consensus of rhinitis
guidelines.
▸ The use of ICT can
facilitate communication
between clinicians,
patients, pharmacists and
other stakeholders.
▸ This project aims to use ICT
systems to tackle
heterogeneity in AR
management across Europe.
▸ The clinical trial is being
planned; but the uptake of ICT
in other studies has been poor.
Conlan et al
(2015)39
Ireland Retrospective cohort
study
Review of
1. New allergy referrals to
adult specialist clinic.
2. A pilot email
communication service
with non-specialists.
✓ ✓ ▸ A majority of patients
referred to secondary care
had chronic spontaneous
urticaria or angioedema.
▸ Food/drug allergy or
intolerance accounted for
about a quarter of all
referrals.
▸ Studies examining referral
patterns can be helpful in
planning services locally by
targeting education of
non-specialists.
▸ New models of care
delivery should be tried to
▸ Study designed to help service
planning locally design may be
generalisable whereas findings
are not.
▸ The uptake of email service
was perhaps lower than
expected. Also the response
rate to the survey was poor
Continued
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Table 1 Continued
Author, (year) (ref)
Level
Region Type of study Study aim 1° 2° Salient findings Key recommendations Comments
▸ The email service did not
show demonstrable impact
on referral numbers.
▸ It was rated as useful by
those clinicians who
responded to the survey.
help ease demand on
specialist allergy centres.
(35%) which makes the
usefulness of the service
difficult to gauge.
Chan et al (2015)40 Hong
Kong
Report To discuss the current
management of allergic
disease in Hong Kong.
✓ ▸ Despite increasing demand,
allergy services and training
remain poor. There are
dedicated allergy services
in public hospitals for
adults.
▸ Laboratory support for
allergy and immunology is
inadequate.
▸ 2 pilot ‘Hub and spoke’
centres catering for adult
and paediatric allergy
should be established.
▸ Training programme in
paediatric and adult
immunology and infectious
diseases should be
extended to allergy.
This is a report from the Hong
Kong allergy alliance, whose
members include patients,
clinicians, academics, industry
and other stake holders in allergy
within Hong Kong.
Jutel et al (2013)24 Europe Report/cross-section To provide a contextual
patient-centric framework
based on opinion of PCPs,
specialists and patients.
✓ ▸ Access to specialist
services was identified as
the ‘greatest unmet need’.
▸ In public health services,
waiting time for secondary
care is usually > 6 weeks.
▸ Current dominant model of
allergy care in Europe is
specialist based, but this is
unsustainable.
▸ Groups across Europe
need to learn from shared
experiences to generate
political will to enable
change to services.
▸ Patient involvement and
empowerment should be
strongly encouraged.
The authors of this publication
belong to the EAACI Task Force
for Allergy Management in
Primary Care.
Jones et al (2013)41 UK Survey/retrospective To assess patients
perception of usefulness of
the secondary allergy
clinic at Plymouth Hospital.
✓ ▸ A third of the patients did
not find the clinic useful.
▸ Half continued to have
troublesome symptoms.
▸ 10% do not feel confident
about managing their
allergies.
▸ There is a need for
follow-up of most patients
with allergy to reinforce
education.
▸ Specialist clinics should try
to obtain routine feedback
from patients to monitor
effectiveness.
▸ Patients who attended clinic
over a 11 year period were
surveyed, 36% response rate
(336/933).
▸ No description of services
offered or the competencies of
the clinicians.
Agache et al
(2012)7
Europe Survey/cross-section To assess the actual
status of allergy
management in primary
care across Europe
✓ ▸ Two-thirds of PCPs do not
have ready access to
allergy specialists.
▸ The average waiting time to
see a specialist in a public
health service was more
than 6 weeks.
▸ Referring patients to organ
specialists is much easier
than referral to an allergist.
▸ A thorough assessment
needed to understand
demands on services and
facilities available to PCPs.
This can be used to adapt
allergy pathways for
primary care.
▸ To develop a structured
development and
information platform for
PCPs.
▸ The study was carried out by
an EAACI task force.
▸ Surveys sent to the national
societies of EAACI member
countries and to individual
members of EAACI as well as
the international primary
respiratory group.
Continued
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Table 1 Continued
Author, (year) (ref)
Level
Region Type of study Study aim 1° 2° Salient findings Key recommendations Comments
Sinnott et al
(2011)23
UK Prospective planning
and implementation of
care pathways
Description of a pilot
project undertaken to
improve allergy services in
the North of England.
✓ ▸ Poor training of PCPs leads
to inappropriate referrals
due to lack of confidence in
managing allergies.
▸ Specialist services are often
deluged with patients who
could have been managed
in primary care.
▸ Variable tariffs for allergy
pose a disincentive for
trusts to develop services.
▸ Postcode lottery exists
especially for those with
severe allergies.
▸ Linking clinicians with an
interest in allergy is a good
way to improve standards
and increase awareness of
patient pathways.
▸ Developments should
support existing service
provision.
▸ Commissioners need to be
educated regarding the
impact of allergies.
▸ Good transition between
adult and paediatric
services needed.
▸ £1.8 million pump priming for
services from the DoH, UK.
▸ Getting commissioners in the
NHS interested in improvement
of allergy services was
challenging.
▸ The project helped formation of
a specialist nurse group in the
region as well as a good
network of clinicians interested
in allergy.
Warner and Lloyd
(2011)42
UK Discussion/pathway
development
Background for the
development of paediatric
allergy care pathways by
the Royal College of
Paediatrics and Child
Health (RCPCH)
✓ ✓ ▸ The pathways are aimed at
commissioners, health
professionals, patients,
parents and carers.
▸ They aim to provide a
bench-mark for service
provision.
▸ Eight pathways developed
by six multidisciplinary
working groups.
▸ The authors define
competencies rather than
criteria for onward referral,
so that guidance can be
applicable even when there
are regional variations in
service provision
▸ Existing literature was
systematically reviewed to
identify ideal pathways for care
and competencies required.
▸ Pathways for anaphylaxis,
asthma/rhinitis, drug allergy,
eczema, food allergy, latex
allergy, urticaria and venom
allergy were proposed.
Royal College of
Physicians and the
Royal College of
Pathologists
(2010)21
UK Report from a publicly
funded organisation.
Recommendations to
stakeholders in allergy for
provision of cost-effective
improvements in allergy
care.
An update on changes to
allergy service provision
following the House of
Lords inquiry (2007) into
allergy.
✓ ✓ ▸ Services remain poor and
highly inequitable.
▸ Some progress since 2007
– Additional trainees in
adult and paediatric
allergy were appointed.
– The Northwest SHA
spearheaded a pilot into
restructuring of allergy
services.
– NICE had adopted a few
projects for issuance of
guidelines.
▸ Some areas of concern
remained unaddressed
including:
– Poor coding of allergy
clinical work.
– Patient engagement
underused
▸ Services should join up to
serve the population of a
defined geographic area.
▸ Validated Patient Reported
Outcome Measures
(PROMs) need to be
developed to evaluate the
effectiveness of services.
▸ Quality Assurance
schemes should be
developed for clinical
allergy services.
▸ Protocols and guidelines
should be shared freely
between centres.
▸ More allergy training
should be incorporated into
PCP and medical student
curriculum (and all other
related specialty training)
▸ Working party for this report
consisted of clinical experts
and patient representatives
from all over the UK.
▸ Data from the pilot study in
North West were discussed in
the report.
▸ Selected publications were
reviewed (non-systematic).
▸ Views from charities supporting
patients with allergy also
represented.
▸ Concerns expressed about the
lack of funding for outcome
evaluation with allergy service
remodelling in the North West.
Continued
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Table 1 Continued
Author, (year) (ref)
Level
Region Type of study Study aim 1° 2° Salient findings Key recommendations Comments
– Governance and training
within existing services
remains poor.
– Occupational allergy
provision remains poor.
▸ Serious deficiencies found
in the commissioner’s
knowledge of the allergy
needs of the local
population.
▸ PCP survey in 2009
showed that most (70%)
continued to rate NHS
allergy services as poor
(similar to 2002 survey).
▸ Clinical services should
establish good links with
the local patient groups.
▸ There should be better
allergen labelling.
Levy et al (2009)43 UK Prospective; no
control group.
Evaluation of a PCP with
special interest clinic in
allergy.
✓ ▸ Two-thirds of the patients
would have been referred to
secondary care in the
absence of this clinic.
▸ Less than 10% of those
reviewed were referred onto
a tertiary clinic.
▸ The clinic was estimated to
have saved £13,500 in
9 months due to reduced
referrals.
▸ Second-tier clinic in
primary care has the
potential to be clinically
effective as well as
cost-effective.
▸ It encourages care in the
local community and can
reduce the burden of
inappropriate referrals to
tertiary centres.
▸ Referrals proforma provided
information on how the clinic
was used by other PCPs.
▸ Consultation satisfaction
questionnaire captured patient
experience.
Working group of
the Scottish Medical
and Scientific
Advisory Committee
(2009)22
UK Report from a publicly
funded organisation.
To report on the diagnostic
and clinical allergy
services within Scotland
✓ ✓ ▸ High burden of allergy in
Scotland; 30% children and
25% adults are affected.
▸ The levels are rising for all
conditions (except perhaps
asthma) and services have
only improved marginally
since last report in 2000.
▸ There are insufficient
numbers of medical
specialists, trainees, PCPs,
dieticians, nurses and
pharmacists trained in
allergy.
▸ Service is fragmented with
no collaboration between
primary, secondary and
tertiary services.
▸ Primary care staff should
have access to basic initial
and ongoing training.
▸ There is a need to
encourage and facilitate
standardised and
evidence-based practice
through shared protocols
and pathways.
▸ Data collection, audit and
research facilities in allergy
should be improved to
ensure better future
planning of services.
▸ Regional MCN for adult
allergy and a national MCN
for paediatric allergy
services are needed.
▸ The authors commented on
the non-availability of trained
specialists and the
▸ underusage of non-physician
services for allergy
(pharmacists, dieticians, nurse
specialists).
▸ Improved motivation via
incentives should be planned.
▸ PCP with special interest may
be a useful resource.
Continued
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Table 1 Continued
Author, (year) (ref)
Level
Region Type of study Study aim 1° 2° Salient findings Key recommendations Comments
▸ Dietetic services
fragmented and patchy and
are not always backed up
with clinician support.
▸ Allergy curriculum in
undergraduate and
postgraduate medical
training needs improving.
▸ Involvement of voluntary
sector should be
encouraged to publicize
the deficiencies in service.
Haahtela et al
(2008)32
Finland Prospective;
intervention; no
control group.
Nationwide allergy
programme being adopted
in Finland. Proposed to
run between 2008 and
2018.
✓ ✓ ▸ Project is currently
underway. Its goals include:
– Prevention of allergic
symptoms.
– Increase tolerance
against allergens.
– Improve allergy
diagnostics.
– Increase resources for
allergy management.
– Decrease healthcare
costs due to allergies.
▸ For each of the five
identified goals, specific
tasks, tools and evaluation
methods have been
defined.
▸ This project is based on
very close collaboration
between the government,
healthcare sector and
non-governmental
organisations.
▸ Emphasis is on tolerance
and not on allergen
avoidance.
▸ The project builds on the very
successful Finnish asthma
model.
▸ Being followed in other
countries (Norway, UK),
preliminary results are
expected soon.
House of Lords
Science and
Technology
Committee, 6th
report of session
2006/7 (2007)18
UK Report from a publicly
funded organisation
To explore the impact of
allergy in the UK upon
patients, society and the
economy as a whole.
✓ ✓ ▸ Allergy exerts a
considerable social and
economic burden upon the
nation.
▸ There is a severe shortage
of allergy specialists in the
UK and the services lag far
behind those of many
countries in Western
Europe.
▸ There are problems with
data collection rendering
statistics imprecise and
affecting service
redevelopment plans.
▸ There has been a chronic
lack of training of PCPs and
medical trainees in allergy,
leading to problems with
diagnosis and management
at the primary care level.
▸ Improved education of
medical practitioners to
diagnose and treat
occupational allergies
needed.
▸ Improve undergraduate
and PCP allergy training.
▸ New centres should build
on existing excellence.
▸ Some specialist services
can be restricted to few
centres across the country.
▸ Educators and
Commissioners should
work together to develop
generic quality assured
clinical post graduate
allergy courses.
▸ NICE to appraise
immunotherapy and
cost-effectiveness.
▸ This report was published by
the allergy subcommittee UK
House of Lords Science and
Technology Committee 2007.
▸ Recommendations made for
non-NHS management of
allergies (eg, training teachers
in managing allergic
emergencies, supporting
children with hay fever during
school examinations, helping
those with occupational
allergies return to work,
improving allergen food
labelling, etc).
▸ Authors visited numerous
national and international
allergy centres of repute to
compile this report.
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Table 1 Continued
Author, (year) (ref)
Level
Region Type of study Study aim 1° 2° Salient findings Key recommendations Comments
▸ Further research into the
basis of allergy is urgently
needed to underpin further
public health policies to
address the rise the
allergies.
▸ Large, tertiary centres led
by allergists should be
developed to ensure
optimal treatment of
patients with complex and
severe disease and also as
sources for education and
training for other clinicians.
▸ A lead health authority
should be identified by the
Department of Health in
order to establish a pilot
tertiary allergy centre. A full
cost analysis should be
integral to its
establishment.
Department of
Health (2007)44
UK Report from a publicly
funded organisation.
Response to the report
from the House of Lords
Science and Technology
Committee 2007.
✓ ✓ ▸ No published whole system
models of services for
people with allergy.
▸ No data on existing skills.
▸ There are also no analyses
of effects of active demand
management of patient
flows in allergy care.
▸ No data on allergy needs in
various regions across the
country.
▸ The royal colleges should
work together to set up
curricula for health
professional training in
allergy.
▸ Health commissioners
should work with local
service providers to ensure
best possible service
planning for their
catchment areas.
▸ Much clearer
understanding of skills and
competencies of the
existing workforce needed.
▸ NICE advised to provide
guidance on allergen
immunotherapy.
▸ Funding identified for an
allergy centre in the North
West region of England.
▸ Most of the recommendations
from the House of Lords report
could not be acted upon due to
insufficient and unreliable data
on the existing state of allergy
management, according to this
report.
Warner et al (2006)3 Worldwide Cross-section;
Questionnaire survey.
To define the current state
of allergy training and
services in the countries
represented within the
WAO
✓ ▸ Prevalence rates for
allergies in the responding
countries ranged from 7.5%
to 40% (mean 22%).
▸ Number of certified
allergists varied widely from
1:25 million in Indonesia to
1:16,000 in Germany.
▸ Formal certification
procedure is not available
for clinicians in some of the
countries surveyed.
▸ There is a very wide gap
between demand and
provision of allergy
services worldwide.
▸ Training of medical
students, general
practitioners, generalists as
well as system specialists
who deal with allergy must
improve to ensure better
care provision.
▸ Survey sent to all WAO
national society member
organisations to be completed
by allergists knowledgeable
about services within their own
countries (61 sent, 34
responses received).
▸ Data based on impressions of
these experts in some
countries rather than on
published data.
Continued
Diw
akarL,etal.BM
J
Open
2017;7:e012647.doi:10.1136/bm
jopen-2016-012647
9
O
p
e
n
A
c
c
e
s
s
Table 1 Continued
Author, (year) (ref)
Level
Region Type of study Study aim 1° 2° Salient findings Key recommendations Comments
▸ In most countries, patients
are first referred to
organ-based specialists
before being referred to
allergists.
▸ More tertiary level centres
needed to set the
standards, advance
research, support training
and provide expertise to
primary and secondary
care.
Department of
Health (2006)45
UK Report from a publicly
funded organisation.
Review of allergy services
undertaken to fulfil
Government of UK’s
commitment to the House
of Commons Health
Committee.
✓ ✓ ▸ No compelling evidence on
need or on quality of allergy
services since relevant
research lacking.
▸ Patients feel let down by a
poor and often inaccessible
service.
▸ Specialist services are
usually not available,
resulting in very long waits
to see consultants where
services do exist.
▸ Self-care can be particularly
useful in allergy and should
be promoted.
▸ Some conflict between the
main two specialities
offering allergy services in
the UK (ie, allergy and
clinical immunology).
▸ Local commissioners need
to establish levels of need
for services for allergy in
their health community.
▸ Educators and
Commissioners should
work together to create
additional training spaces
for doctors.
▸ Guidelines for
management and care
pathways should be
developed by NICE.
▸ Data obtained by review of
existing literature and also by
interviewing stakeholders.
▸ Highlights the difficulties in
developing national strategy for
allergy services without
baseline data on needs and
costs involved.
▸ It is important to understand
the skills and competencies
that exist and those that are
needed from the diverse
workforce to enable future
development and provision of
services.
El-Shanawany et al
(2005)46
UK Cross-section;
Questionnaire Survey
To survey allergy services
provided by clinical
immunologists in the UK.
✓
✓
▸ Immunology centres are the
only providers of tertiary
allergy care for most of the
UK.
▸ Consultant immunologists
are likely to be providers of
tertiary level allergy care in
the medium and long term
for the UK.
▸ Waiting times for allergy
patients in these clinics
were long, sometimes
waiting over a year for
urgent appointments.
▸ Very few centres benefitted
from dietician support.
▸ There needs to be a
collaborative effort between
clinical immunologists and
allergists in the UK in order
to improve services.
▸ Questionnaires sent via three
supra-regional immunology
audit groups to the various
participating immunology
regional centres in the country.
▸ 17 immunology centres serving
a total population of 32 million
individuals responded.
Continued
10
Diw
akarL,etal.BM
J
Open
2017;7:e012647.doi:10.1136/bm
jopen-2016-012647
O
p
e
n
A
c
c
e
s
s
Table 1 Continued
Author, (year) (ref)
Level
Region Type of study Study aim 1° 2° Salient findings Key recommendations Comments
Ryan et al (2005)47 UK Discussion To propose minimum
levels of knowledge
required for clinicians in
order to improve standards
of allergy care.
✓ ✓ ▸ Self-care in allergy is
problematic due to the poor
access to NHS healthcare
and the availability of
unregulated alternate
practitioners.
▸ PCPs and practice nurses
could be better trained in
prescribing drugs for
allergy.
▸ Intermediate care services
(eg, PCP with special
interest) should be
developed.
▸ Pharmacists, primary care
nurses and physicians
could be trained in a few
allergy-related techniques
to vastly improve service
provision.
▸ The authors suggest that
management of allergy in
primary care can be improved
even when specific tests and
other infrastructure are
unavailable.
▸ Knowledge of
pharmacotherapy for allergy
can help PCPs manage a
majority of patients.
Department of
Health (2005)48
UK Report from a publicly
funded organisation
Government of UK
response to the House of
Commons Health
Committee report.
✓ ✓ ▸ Good quality data on needs
and services for allergy is
lacking.
▸ Service models for
managing allergy in primary
and secondary care could
be developed.
▸ Medical regulatory bodies
overseeing physician and
nurse training should be
encouraged to increase
allergy educational content
during training.
▸ Self-care should be
encouraged; NHS led
expert patient programme
will be extended to allergy.
▸ Food Standards Agency
has produced a guide for
those recently diagnosed
with food allergies.
▸ Local commissioners
should establish need for
services in their local area.
▸ It was felt that a review of
available data and research on
allergic conditions is necessary
in order to plan future direction
of allergy services. This formed
the basis for a separate report
(as above).
Levy et al (2004)49 UK Cross-section;
Questionnaire survey
Understanding the views
of PCPs in the UK
regarding the quality of
primary and secondary
care for allergy.
✓ ▸ More than 80% felt that the
NHS allergy care was poor.
▸ Primary and secondary
care services were thought
to be deficient.
▸ Very few (4%) offered skin
prick tests at their practice.
▸ Most expressed concern
regarding managing
children with allergies.
▸ A majority were confident in
the management of
urticaria, allergic rhinitis,
angioedema, anaphylaxis.
▸ National education
programmes should be
developed for PCPs.
▸ Specialist care provision for
allergy should be reviewed
urgently within the NHS.
▸ Randomly selected sample of
500 PCPs from UK General
Practice register were
contacted.
▸ Only 50% response rate.
House of Commons
Health Committee
(2004)19
UK Report from a publicly
funded organisation
To highlight the need for
allergy service
improvement in the UK
✓ ✓ ▸ Primary care skill base for
allergy is poor—this is
compounded by weakness
in secondary care sector as
well.
▸ Allergy specialist centres
need to be developed
manned by allergists;
allergists cannot be
substituted effectively by
other specialists.
▸ Health committee comprising
of elected representatives.
▸ Expert interviews, statistics
from published sources,
submissions to panels from
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Table 1 Continued
Author, (year) (ref)
Level
Region Type of study Study aim 1° 2° Salient findings Key recommendations Comments
▸ Current provision is
manifestly inequitable and
more allergy specialist
centres are required.
▸ Better secondary care can
help improve primary care
knowledge and services.
▸ Paediatric services are
worse than adult services
—school nurse training,
transition services, dietary
recommendations, etc, all
need improving—-specialist
services can help improve
school staff training in
allergy by taking on
leadership for this.
▸ Poor and sometimes
dangerous practice exists in
the independent sector.
▸ Data on waiting times are
flawed, and this adversely
affects service planning.
▸ Advocated the
establishment of national
primary care allergy
network.
▸ Ongoing training for allergy
in primary care needs to
improve; services should
be peer reviewed.
▸ Introduction of clinical
quality markers for allergy
to incentivise improvement
advised.
▸ PCP curriculum needs to
be modified to include
more allergy.
▸ Separate coding for allergy
needs to be introduced
(now available).
▸ Investment in allergy
training required.
individuals – patients or carers
(300 letters) were all used.
Royal College of
Physicians (2003)20
UK Report from a publicly
funded organisation.
To ensure that allergy
services are prioritised for
improvement by
commissioners and
managers in the NHS.
✓ ✓ ▸ Allergy incidence and
prevalence is increasing but
services are quite poor.
▸ Very few allergy specialists
in the country and few
trainees in the pipeline.
▸ General practitioners not
trained to cope with the
increasing demands for
allergy treatment, most do
not feel confident about
services, but very few
patients are referred to
specialists, nonetheless.
▸ Few centres offer
secondary care allergy; six
centres UK wide offering
tertiary care. Hence PCPs
not sure who to refer
patients to.
▸ Need to have increased
allergy specialists (rather
than other specialists who
are untrained in allergy).
▸ Important to develop
regional allergy centres
that can help with
education, training and
networking between
primary and secondary
care in the region (‘Hub
and spoke’ configuration).
▸ More doctors should be
trained to become allergy
specialists.
▸ 40 new training posts in
allergy will be required.
▸ Patient groups and
charities must become
more active and lobby for
better services.
▸ Working party consisting of
clinical experts from all over
the UK, patient representative.
▸ Selected publications reviewed
(non-systematic).
▸ Other interested stakeholders
interviewed, including
clinicians, charities supporting
patients with allergy, individual
patients.
▸ Two parts to the report—one
covering allergy services and
recommendations for
improvements and the other
covering common allergic
conditions and their
management.
Continued
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Table 1 Continued
Author, (year) (ref)
Level
Region Type of study Study aim 1° 2° Salient findings Key recommendations Comments
▸ Increasing emergency
admissions for allergy.
▸ Some papers quoted to
suggest specialist services
may be cost-effective.
▸ There is a need for more
dieticians and nurse
specialists in allergy.
Ewan and Durham
(2002)33
UK Discussion Proposal to improve NHS
allergy care in the UK
✓ ▸ NHS allergy service
provision is inadequate and
inequitable.
▸ Estimate that there is one
whole time equivalent
allergist per 3.4 million
population in the UK.
▸ Only six clinics in the UK
offer services of full time
NHS allergists.
▸ Each of the health areas in
the UK should have a
regional specialist centre to
provide clinical expertise
and training.
▸ More training posts in
allergy should be created.
▸ Data derived from the BSACI
and BAF database.
▸ Authors assume that part-time
allergists provide 0.3 WTE and
other specialists provide 0.1
WTE allergy work per week.
This is debatable.
Ewan (2000)50 UK Discussion An overview of NHS
allergy services and
suggestions for
improvement.
✓ ▸ There are serious
deficiencies in the allergy
services within the UK.
▸ Training numbers for allergy
are not adequate to serve
current and future demands
on the specialty.
▸ Organ specialists (including
immunologists) not
appropriately trained for the
holistic management of
these patients.
▸ Minimum of 1 regional
allergy centre per region
needed manned by allergy
specialists and nurses,
dietician.
▸ Organ-based specialists
and allergists need to be
appointed to more
secondary level centres.
▸ There should be an
increase in specialist
training spaces for allergy.
▸ Data from BSACI and BAF
database as above.
▸ Recommendations as per the
Allergy task force set up by the
BSACI and DoH in 1998.
Brydon (1993)51 UK Questionnaire;
retrospective
A survey to determine the
effectiveness of a nurse
practitioner service.
✓ ▸ Nurse led service resulted
in fewer general practitioner
consultations and also a
reduction in prescribed
medication for allergy.
▸ Most respondents reported
an improvement in
symptoms.
▸ Better results seen in
patients who were followed
up for longer.
▸ Using nurse led services in
primary care can be cost
saving.
▸ There could have been a
recruitment bias/criteria for
choosing a section of
patients not made explicit.
▸ Bespoke postal questionnaire
before and 9 months after
appointment with the nurse.
▸ Responses compared with
patient notes from PCP.
BAF, British Allergy Foundation; BSACI, British Society of Allergy and Clinical Immunology; DoH, Department of Health (UK); EAACI, European Academy of Allergy and Clinical Immunology;
MCN, Managed Clinical Network; NHS, National Health Service (UK); NICE, National Institute of Health and Care Excellence, UK; PCP, Primary Care Physician; PROM, Patient Reported
Outcome Measures; WTE, Whole Time Equivalent; WAO, World Allergy Organisation.
Level: 1° (primary) refers to care delivered by primary care physicians, nurses and other practitioners who are non-specialist and offer services in the home or community.
2° (secondary) services refer to those provided in hospitals by clinicians (doctors or nurses) deemed to have specialist training and knowledge relevant to the management of the condition.
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Seven of the publications discussed allergy services in
other parts of the world,3 7 24 32 38–40 whereas the rest
are focused speciﬁcally on services in the UK. Of the 19
UK papers, 8 are reports published by governmental
organisations discussing the state of allergy services in
the UK.18–22 44 45 48 One of these reports provides a
brief overview on aspects of allergy services in other
European countries (Germany and Denmark).18
Another summarises experiences following the establish-
ment of a pilot allergy service in the North West of
England.23
Reorganisation of primary care was addressed by seven
articles, secondary care services were the focus of six
publications, whereas four papers discuss both levels of
care. The eight government reports discuss all aspects of
service delivery (table 1). Three studies discussed the
use of digital technology-based interventions for
allergy,37–39 one of these retrospectively evaluated such a
service.39 Findings, statements and recommendations
about allergy service pathways from the included papers
are reported in table 1 and are synthesised thematically.
Primary care services
PCPs in allergy service delivery
PCPs are the ﬁrst-line providers of healthcare in most
countries around Europe.24 They are well placed to
provide diagnosis and management of mild and most of
the moderate allergic conditions as well as to refer indi-
viduals with complex and severe allergies to specialist
services.24 Many publications have identiﬁed that the
training offered to PCPs in allergy currently is inad-
equate.18–23 47 49 The current inadequacies in training
and the need for more information and training for
PCPs in allergy were reinforced in studies reported from
Scotland, Italy and Spain.7
It was argued in the two European publications that a
model of care which is centred on specialists or consul-
tants is untenable in allergy.7 24 In public-funded health
systems such as the UK where PCPs assess and manage
the majority of patients, the burden placed by allergy
and related conditions on primary care could be signiﬁ-
cant. For example, it was estimated that allergy accounts
for 8% of all general practice consultations in the UK
and that up to 11% of the total drugs budget is spent on
allergy-related medication (including asthma and
eczema).18
One particular article mentioned the lack of access to
secondary services as allergy’s ‘greatest unmet need’.7
Referral times to specialists vary considerably across
Europe from over 3 months in some tax-funded health
systems7 20 22 40 to as little as 1 week when specialists can
be accessed privately.7 Across Europe organ specialists
are generally more readily accessible to PCPs than aller-
gists.7 In a UK-based survey of over 480 PCPs, 81.5% of
the 240 PCPs who responded felt that the NHS allergy
services were poor and 80% felt that secondary care pro-
vision was inadequate.49 These practitioners admitted to
being especially anxious about treating children with
food allergies, although most felt quite conﬁdent about
managing common allergic conditions such as anaphyl-
axis, urticaria, allergic rhinitis and drug allergy.49
PCPs with an interest in allergy
Two publications speciﬁcally discussed a second tier
service for allergy within primary care.7 53 Such an
arrangement was also proposed by the House of Lords
report.18 In the UK, a prospective evaluation of patients
referred to a General Practitioner with Special Interest
(GPwSI) in allergy revealed that the services were well
received, reduced the levels of secondary care referral
and had a potential for cost savings.43 Further, PCPs in
this study referred patients more readily to the GPwSI
than to secondary care.43 However, establishing these
services would need a well-deﬁned process of accredit-
ation and specialist mentorship24 which may be difﬁcult
to achieve in most countries given the current severe
shortage in the availability of specialists across
Europe.3 24
Non-physician services in primary care
Non-physician services for allergy were speciﬁcally dis-
cussed by six publications in this review.18 20 22 44 47 51
Most of the articles discuss the underusage of these pro-
fessionals in allergy and suggest that there is a scope for
better training of nurses, pharmacists and dieticians in
allergy. Depending on the extent of training and the
competencies achieved, nurses could be involved with
testing, diagnosis and management of patients with
allergy.47
Some authors felt that pharmacists could, if
adequately trained and sufﬁciently supervised, provide
information to patients regarding techniques for using
devices such as nasal sprays, eye drops, epinephrine
auto-injectors as well as inhalers for allergy and related
conditions.18 47 They could help patients choose over
the counter medication for allergy judiciously. They can
also be trained to advice individuals on the need for
consultation with their PCP, where appropriate.22 The
House of Lords committee suggested that pharmacists
should be formally trained in allergy to ensure that
good quality advice on allergy medication can be pro-
vided to all patients.18 This committee also reported
concerns from clinicians regarding availability of unval-
idated tests over the counter for allergies in some estab-
lishments.18 There are, however, no publications to-date
formally assessing the role of pharmacists in the diagno-
sis and management of allergy.
Barriers to providing optimal allergy care in the primary care
sector
Several authors were concerned that PCPs do not receive
structured instruction in allergy during their training,
and very few are familiar with guidelines for the manage-
ment of allergic disease.7 20–22 33 The House of
Commons health committee highlighted the lack of
allergy knowledge in primary care as “…one of the
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principal causes of distress to patients”.19 Some articles
have speciﬁcally highlighted the signiﬁcant gaps in
allergy training at the undergraduate and postgraduate
levels, as well as inadequate continuing medical educa-
tion programmes for PCPs in allergy.20 21 24 This was
identiﬁed as leading to inappropriate referrals to a range
of specialists,23 lack of engagement with secondary care
services for allergy, delays in diagnosis and starting appro-
priate management20 and, sometimes, to inappropriate
management.33 All these issues resulted in poor patient
experience and also cause a signiﬁcant wastage of scarce
healthcare resources.20 21 A retrospective review of the
patients at a secondary care allergy clinic in Sussex
showed that at least 42% of patients were referred for
conditions that could have easily been managed in
primary care, had the PCPs been appropriately trained.36
An Irish study also suggested that increasing awareness of
common allergic conditions among PCPs can signiﬁ-
cantly reduce referrals to specialists.54 This suggestion
was reinforced in UK government reports19–22 and other
studies.23
In most countries, the lack of leadership and support
offered by a stable, well-staffed specialist service was iden-
tiﬁed as one of the main barriers to improvement of
primary care services.7 18–21
Secondary care services
Availability of specialist services
A publication by the World Allergy Organisation (WAO)
has suggested that there is a great degree of heterogen-
eity in access to specialist allergy services across the
world.3 40 Experts point out that while there has been
very little increase in availability over the last few years,
the demand for specialist allergy services has been stead-
ily increasing.21 For example, the number of certiﬁed
allergy specialists per head of population range from
1:25 million (in Malaysia) to about 1:2 million (in the
UK) and 1:16 000 (in Germany).3
Heterogeneity in specialist training has also been high-
lighted3 33 with only a few countries providing certiﬁed
courses to practitioners in allergy. A worldwide study by
the WAO showed that paediatric allergy services are par-
ticularly underserved and children with allergic problems
are often managed by general paediatricians with or
without formal allergy training.3 This study also found
that in many countries children may be managed by spe-
cialist adult physicians without appropriate paediatric
training.3 Specialist training pathways for allergy vary
markedly worldwide. In countries such as the UK, formal
certiﬁcation procedures in either allergy alone or in a
combination of allergy and immunology exist. Similarly,
in the USA, allergists/immunologists should have passed
a professional examination taken after 2 years of struc-
tured specialty training. In other countries, allergy may
be included as a subspecialty in general internal medi-
cine or paediatrics training.3 In Germany, for example,
allergology is considered a subspecialty of dermatology.18
In the UK, the British Society for Allergy and Clinical
Immunology (BSACI) has estimated that 90% of second-
ary care in the UK is provided by allergists and immunol-
ogists.45 A study carried out in the UK has shown that
immunologists, who have formal training in allergy,
provide allergy care to 32 million individuals in the UK.46
Some authors have pointed out that immunologists are
indeed the sole providers of allergy services in parts of
the UK.44 46 Other specialists such as those with primary
qualiﬁcations in ENT, respiratory medicine or dermatol-
ogy also contribute to the delivery of allergy services in
many countries3 including about 10% of the total second-
ary care for allergy in the UK.45 Even if this broad deﬁn-
ition of allergy specialists were to be accepted, many
experts feel that allergy services remain inadequate in
most countries in the face of increasing demand for
these services.3 19 40
Specialist centres for allergy
Some authors propose the ‘hub and spoke’ model18–20 40
which involves the establishment of supraregional tertiary
allergy centres (or Hubs) which can support regional sec-
ondary and primary care centres (the so-called spokes)
for delivery of specialist services. A few suggested that
these centres should be manned by consultant adult and
paediatric allergists, nurse specialists as well as adult and
paediatric dieticians while providing facilities for training
at least two specialist registrars in allergy.20 Others felt
that these should be multispecialist centres (eg, chest
physician, dermatologist, ENT specialist, paediatrician in
addition to an allergist or clinical immunologist) that are
built on existing expertise of the local area and serve as
‘clusters of expertise’.18 In some countries, these centres
would typically be university hospitals which would
receive referrals only from specialists.18
Whatever their composition, most agreed that these
centres could serve to educate and support primary and
secondary care physicians in the region.18–20 It was sug-
gested that they had a potential to serve as centres of
excellence for adults and children with complex and
severe allergies; establish a good, working network
between organ-based specialists, generalists and allergists
and serve to improve the overall provision of allergy ser-
vices in the region.18
Some experts point out that the existing shortage of
specialists in allergy would be a barrier to the develop-
ment of such centres.21 50 A pilot study carried out in
the North West region of England found that developing
large tertiary centres would not be practical in regions
with large cities in close proximity to one another.23
They may not be cost-effective for many regions within
the UK21 and perhaps, Europe.
The House of Commons health committee has
pointed out that there are no clear data to suggest that
specialist centres improve clinical outcomes in allergy
management.19 41 Indeed, even in countries like
Germany with a relatively high proportion of allergy spe-
cialists per 100 000 population, the numbers of emer-
gency admissions for allergy remain high.3 The North
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East England pilot study found that the lack of conﬁ-
dence among general practitioners while dealing with
patients with allergy led to poor referral practices.23 As a
consequence, management of simple conditions took up
a disproportionate amount of specialist time and
resources while individuals with complex allergies faced
long waiting lists as well as inappropriate referrals to
other specialists.23
Future direction for services
While efforts are being made to improve allergy educa-
tion at the undergraduate and postgraduate levels, there
has been a focus also on the improvement of training of
current practitioners. The Royal College of Paediatrics
and Child health has developed care pathways for chil-
dren which deﬁne core competencies for all those
involved in managing these conditions and are freely
accessible online.42 These are UK based but potentially
can be modiﬁed to suit other countries. Such pathways
embrace the current heterogeneity in service delivery
while attempting to raise standards.
The ‘Hub and spokes’ model was trialled in the UK with
mixed results, which was speciﬁcally discussed in a
report.23 The authors suggested that new services should
be tagged onto existing pathways and also stated that a care
model of visiting specialists in secondary centres would be
more welcome in some areas than the establishment of
large tertiary centres.23 It was also suggested that models of
good care can vary from one region to another.21 23
There have been recent publications regarding the
use of digital technology in the provision of allergy ser-
vices.37–39 One addresses the use of telemedicine in
improving communications between primary and sec-
ondary care in order to improve adult allergy pathways
within the NHS;37 whereas another makes a case for
clinical trials using information communication and
technology (ICT) in management of allergic rhinitis in
Europe.38 A publication from Ireland reported on the
use of an email communication system, which received
an average of only four enquiries per month over a
12-month period. Although it was rated useful by 100%
of the responding non-specialists (response rate of
35%), this communication system did not reduce refer-
rals to the specialist allergy services.39
There has been a lot of interest lately in the ‘Finnish
model’ of service reorganisation. This re-structuring
exercise takes inspiration from the successful interven-
tions for asthma in Finland.32 While acknowledging the
differences between asthma and allergy and emphasising
the need to understand and improve tolerance to aller-
gens, the architects of this model hope to use the exist-
ing asthma infrastructure to improve services for allergy
sufferers. They suggest that increased initial outlay
aimed at preventing allergies and changing attitudes
towards health alongside improving service delivery can
reduce the cost and burden of allergic disease in the
future.32 The results of this experiment are currently
awaited.
DISCUSSION
Principal findings of the review
This systematic review aimed to identify and discuss
various pathways that are relevant to the delivery of
allergy services. There were large gaps in the literature
pertaining to services in countries with high rates of
allergy (such as Australia, New Zealand, USA)1 5 as well
as very populous regions of the world including China,
India, Brazil and the whole of Africa. In addition, there
was a lack of well-designed studies in this area with only
three prospective studies identiﬁed.23 32 43 None of the
studies included a control group. Two of these publica-
tions23 32 describe service reorganisation on a large scale
with direct involvement of the relevant health ministries.
There is clear evidence from the literature that allergy
services across the world have not kept up with rising
demand. The ‘allergy epidemic’13 has surprised unpre-
pared health systems globally. There has been failure on
the part of governments and fund holders to acknow-
ledge the rapid rise in allergies. Given that there are no
signs of abatement in the observed increase in allergies
worldwide,2 it is conceivable that the demand on services
is set to increase even higher over the next few years. The
psychosocial impact of these conditions is often over-
looked. For example, atopic individuals experience sig-
niﬁcantly worse memory and cognitive ability during
allergy season.55 Children with eczema report higher
levels of anxiety and depression.56 In addition, these con-
ditions currently place an inordinate ﬁnancial burden on
healthcare services.29 57 58 Urgent and effective measures
are therefore needed to cope with the problem.
About three-quarters of the eligible publications in this
review (18/23) are from the UK which suggests that there
has been a lot of interest here in investigating the extent
of the supply gap in allergy services over the last 15 years.
It is striking however, that while most of these reports
describe the problems with service delivery and suggest
some solutions, none seem to have addressed the
problem in a structured manner. There has been no
response to the UK Department of Health’s request for
reliable baseline data on needs of the population; costs
involved in service reorganisation; and the skills and com-
petencies of the existing workforce in order that future
services can be planned.44 45 48
Primary care services are key to optimal management
of allergy. Appropriate management after good history
taking and speciﬁc testing can easily be achieved in
primary care for a majority of patients. Referral to spe-
cialist centres can be limited to only complex patients
needing multidisciplinary input or those that need
desensitisation therapy. However, a UK survey has shown
that PCP conﬁdence in managing allergies in children49
and initiating referrals appropriately is limited. While
PCPs in this particular survey felt conﬁdent about man-
aging adults, studies have shown that most individuals
referred to secondary care could have been managed
effectively in primary care.23 54 59 This serves to high-
light the inadequate training received by PCPs in allergy
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at undergraduate and postgraduate levels. This leads to
not only poor patient experience and outcomes but is
also more expensive to the health service providers.
Owing to lack of specialists in allergy, patients are
often referred to specialists who can, perhaps, only deal
with individual manifestations of allergy (eg, respiratory
physicians for allergic asthma; ophthalmologists for aller-
gic eye disease). Organ-based specialists play a very
important role in the management of allergic disease.
Indeed, in some instances (eg, children with very severe
disease), their input is essential. However, specialists in
allergy can provide clinically effective and potentially
cost-effective services by intervening across several of
these conditions for most patients.20
Scarcity and inequity of specialist allergy services is a
recurring theme in many articles worldwide. Although
numerous publications have made a compelling case for
more specialist centres,3 18–21 33 these have not been
forthcoming. Many factors appear to contribute to this
apparent inertia,21 the important ones being lack of
adequate central funding to increase training numbers
for specialists, lack of interest in allergy services among
fund holders,23 lack of clarity regarding the role of
various specialists involved.21 Another important issue is
the lack of formal training programmes in allergy in
many countries.3 This not only blights the care of indivi-
duals with allergy in these countries, but also prevents
the specialty being taken seriously by decision makers.
In the case of the UK, lack of clinical codes to measure
allergy activity and disagreements between the two main
specialist groups that provide allergy services (allergists
and immunologists) are also important issues.48 Further,
in the UK, the lack of specialist services and poor refer-
ral practices within primary care have resulted in unreli-
able waiting list data, which are often used as a surrogate
marker for need within the NHS.44 This has proved to
be a barrier for further investment in services.48
It should be noted that there are no published data
that support the success of large, tertiary centres.
Nevertheless, it is conceivable that centres which treat
large volumes of individuals will provide better outcomes
for complicated patients.60 However, the lack of conﬁ-
dence among general practitioners while dealing with
patients with allergy leads to poor referral practices
leading to long waiting lists as well as inappropriate
referrals to other specialists.23
There have been many encouraging advances in
allergy service reorganisation in the UK and beyond.
New multiconsultant allergy centres were created in the
North West of England as per the recommendations of
the House of Lords report into allergy services.18 This
service development encountered many barriers includ-
ing non-engagement of local commissioners, non-
availability of appropriately trained staff and poor
coding practices.23 Nevertheless, the project was success-
ful in improving networking among specialists across the
region, improved clinical governance including audit,
better regional education programmes for clinical staff
and patients in allergy.23 There was an opportunity
during the course of this project to prospectively collect
data on patient experiences and outcomes, which was
unfortunately missed.
The heterogeneity in specialist training across Europe
is also being addressed with the introduction of the
European Examination in Allergology and Clinical
Immunology since 2008 by the European Academy of
Allergy and Clinical Immunology (EAACI). The aim of
this examination is to “raise standard of allergology and
clinical immunology in Europe” and to “facilitate the
exchange of young people trained in Allergology and
Clinical Immunology” in Europe.61
The Finnish allergy model is based on the very suc-
cessful restructuring of asthma care in Finland62 and is
now being adapted to the management of other chronic
conditions.63 In Finland, the model has been altered to
incorporate the complex and heterogeneous nature of
allergy but it essentially builds on the existing infrastruc-
ture developed for the asthma programme.32 The
Finnish allergy plan is an ambitious project that aims to
reduce the burden of allergic disease by improving toler-
ance and reducing the emphasis on allergen avoidance
in affected individuals. The objective is to help alleviate
the psychosocial aspects of allergy while improving ser-
vices provided to these persons.32 Aspects of this plan
have also been adopted by Norway64 and by a health
authority in North West London as well as in Shefﬁeld.65
Preliminary results from the London project are very
encouraging.31 66 67 More data are awaited to ascertain
whether the project has been successful and also if this
success can be emulated in other regions.
Strengths and limitations of the review
The strength of this review is that it provides a systematic
and comprehensive look at the reported current provi-
sion of allergy services across the world. There are some
limitations to this review, mainly due to paucity of infor-
mation from most countries, including some with rela-
tively high allergy incidence and prevalence, regarding
available services. Most of the literature is UK based and
hence generalisability of data to other countries, espe-
cially those without publicly funded health systems may
be limited. In addition, there were very few well-planned
prospective studies and no controlled studies in this
area. Most of the included studies had little empirical
data, and therefore a formal quality assessment of the
publications was not carried out. Studies not reported in
the English language were excluded.
Strengths and limitations in relation to other studies
This paper is the ﬁrst to comprehensively review all the
published reports and journal articles on allergy ser-
vices. Our review, in concurrence with a previous UK
review,45 found that prospective studies in the area were
lacking and that there were no data objectively compar-
ing different levels of service delivery (eg, primary care
vs secondary care).
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CONCLUSIONS
There is a consensus that allergy services across the
world are inadequate to meet the rising demand. There
is a high degree of heterogeneity and inequity in the
availability of services across the world. Untreated or
poorly treated allergic conditions can have a high psy-
chosocial impact on individuals and can place a substan-
tial economic burden on healthcare services. Allergy
training is not adequately provided in the current under-
graduate and postgraduate medical curricula, which is
adversely affecting patient care at all levels, especially in
primary care. Primary care services are affected by poor
training of practitioners and by poor access to specialists.
Specialist services are hampered by the non-availability
of appropriately trained personnel and poor referral
practices from primary care (where applicable) which
lead to long waiting lists and poor overall patient care.
There is currently no clear consensus on how services
should be structured although the Finnish model of
service reorganisation has shown signiﬁcant promise.
Political engagement and patient empowerment are
important to the success of these projects.
Future research
There is a need for data on service pathways from across
the world, especially from countries with a high burden
of allergic disease so that the extent of the problem can
be identiﬁed and lessons may be learnt from successful
models. Prospective data aimed at estimating the costs
and outcomes of service pathways are especially import-
ant. To ensure that a service is successfully re-organised,
it is important to understand the needs of the local
population, their preferences for services and to esti-
mate costs and beneﬁts of the possible service pathways.
This literature review forms part of a wider project
which aims to achieve these objectives for the popula-
tion of the West Midlands region of the UK.
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